All Type of News
Drug rebate scandals baffle pharmaceutical industry
It is baffling to see large pharmaceutical firms being caught in a series of rebate scandals, industrial officials said.
Earlier this month, the prosecution indicted seven former and incumbent executives of the cou...
KPA proposes 16 drug policies to Park’s transition team
The Korean Pharmaceutical Association (KPA) said Tuesday that it proposed 16 drug-related policies to the presidential transition team of Park Geun-hye.
The KPA’s recommendations include boosting of substitute drug...
564 drug patents listed in 2012
The Korea Food and Drug Administration said Tuesday that a total of 564 pharmaceutical patents (434 drugs) were registered into the green list last year.
Following a stipulation of the Korean-US Free Trade Agreemen...
Local drugmakers lag behind in R&D spending
Korean drug companies are still lagging far behind their overseas counterparts in research and development (R&D) investment, spawning fears that they will lose out.
Aggressive R&D investment has been the main drive...
Wholesaling industry under fire over back margin
The country’s wholesaling industry is under fire over their deteriorating management condition for providing excessive back margins to pharmacies in return for handling their products.
In a congratulatory speech at...
Regional wholesalers to change prescription drugs
Regional wholesalers in Busan, Ulsan and South Kyungsang Province has threatened to change a list of prescription drugs produced by some drug firms that joined the two online drug shopping malls operated by Hanmi Phar...
JW Holdings wins $10 million drug contract
JW Holdings has won a contract to supply $10 million worth of Q-roxin (balofloxacin), a quinolone antibiotic and hair dye Changpo(n) to the Chinese market, the Korean pharmaceutical firm said Monday.
The company sa...
LG Life Sciences to open large-scale research center in Seoul
LG Life Sciences said Monday it will invest 500 billion won in research and development (R&D) over the next five years, with a pharmaceutical and biomedicine research center to be built in Seoul.
In its business i...
Government to raise generic price of innovative drug firms
The Ministry of Health and Welfare said Monday that the insurance price of 15 telmisartan generics produced by five innovative drug firms will be raised from today.
Telmisartan is an angiotensin II receptor antagon...
Price cut measures by drug volume should be scrapped: Industry
Industry officials said that the current system of pricing adjustment by annual drug volume may not contribute to financial stability in national health insurance, claiming the system should be scrapped.
They argue...
